TABLE 1

Features of nonfibrotic smoking-related interstitial lung disease

Respiratory bronchiolitisRespiratory bronchiolitis interstitial lung diseaseDesquamative interstitial pneumoniaPulmonary Langerhans cell histiocytosis
Zonal distributionUpper lobeUpper lobeLower lobe (60%)
Diffuse (20%)
Patchy (20%)
Upper lobe (spares the costophrenic angles)
Clinical findingsAbsentCough and dyspneaCough and dyspneaCough and dyspnea, constitutional symptoms (1/3 of patients) and pneumothorax (15%)
Findings on high-resolution computed tomographyPoorly defined centrilobular ground-glass nodulesPoorly defined centrilobular ground-glass nodules
Patchy ground-glass opacities
Bronchial wall thickening
Reticulation occasionally (no traction bronchiectasis or honeycombing)
Ground-glass opacity (widespread, bilateral and symmetrical in 86%)
Reticular opacities (59%)
Traction bronchiectasis
Honeycombing is uncommon (< 1/3 of patients)
Cysts: bizarrely shaped and nonuniform in size
Nodules: irregular or cavitary, centrilobular and peribronchial in location
Associated featuresCentrilobular emphysema
Air-trapping
Centrilobular emphysema
Peripheral cystic spaces (dilated bronchioles and alveolar ducts)
Characteristic imageFigure 1Figure 2Figures 3 and 4Figures 58
Typical clinical courseUsually asymptomatic; may progress to respiratory bronchiolitis-interstitial lung disease if smoking continuesCough and progressive dyspnea on exertionCough and progressive dyspnea; can progress despite smoking cessationFever, weight loss, nonproductive cough, dyspnea, chest pain; spontaneous pneumothorax also seen
Role of lung biopsyNoneNoneSurgical lung biopsy may be indicated if diagnosis is uncertainSurgical lung biopsy may be indicated if diagnosis is uncertain